← Back to headlines
Portugal Approves New Drugs for Neurodegenerative Disease and Brain Cancer
Portugal's Infarmed has concluded evaluation processes for new medications, including one for the rare neurodegenerative condition Friedreich's ataxia and another for specific types of brain cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.

